The conversation on psychedelics around the world continues to evolve, with more and more emerging clinical data highlighting their potential to treat mental health…
The European Parliament could have helped to stimulate R&D into new drugs for rare diseases if it had not stuck so closely to the…
Bipartisan legislation advancing in the U.S. Senate and the U.S. House of Representatives known as the “BIOSECURE Act” (“the Act”) has the potential to…